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Václav Brázda1,2*, Ilona Klusáková1,3, Ivana Hradilová Svíženská1,3 and Petr Dubový1,3Abstract
Background: IL-6 is a typical injury-induced mediator. Together with its receptors, IL-6 contributes to both
induction and maintenance of neuropathic pain deriving from changes in activity of primary sensory neurons in
dorsal root ganglia (DRG). We used in situ hybridization to provide evidence of IL-6 and IL-6 receptors (IL-6R and
gp130) synthesis in DRG along the neuraxis after unilateral chronic constriction injury (CCI) of the sciatic nerve as an
experimental model of neuropathic pain.
Results: All rats operated upon to create unilateral CCI displayed mechanical allodynia and thermal hyperalgesia in
ipsilateral hind paws. Contralateral hind paws and forepaws of both sides exhibited only temporal and
nonsignificant changes of sensitivity. Very low levels of IL-6 and IL-6R mRNAs were detected in naïve DRG. IL-6
mRNA was bilaterally increased not only in DRG neurons but also in satellite glial cells (SGC) activated by unilateral
CCI. In addition to IL-6 mRNA, substantial increase of IL-6R mRNA expression occurred in DRG neurons and SGC
following CCI, while the level of gp130 mRNA remained similar to that of DRG from naïve rats.
Conclusions: Here we evidence for the first time increased synthesis of IL-6 and IL-6R in remote cervical DRG
nonassociated with the nerve injury. Our results suggest that unilateral CCI of the sciatic nerve induced not only
bilateral elevation of IL-6 and IL-6R mRNAs in L4–L5 DRG but also their propagation along the neuraxis to remote
cervical DRG as a general neuroinflammatory reaction of the nervous system to local nerve injury without
correlation with signs of neuropathic pain. Possible functional involvement of IL-6 signaling is discussed.
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Unilateral nerve injuryBackground
Cytokines and their receptors are involved in many bio-
logical processes, including rapid responses of the nervous
system to injury inducing and maintaining neuropathic
pain. An injury to peripheral nerve initiates a cascade of
cellular and molecular changes involving neurons, glial
cells, and immune cells [1,2]. Neuronal cell functions
in the dorsal root ganglia (DRG) shift from normal* Correspondence: vbrazda@med.muni.cz
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reproduction in any medium, provided the ormaintenance and neurotransmission toward survival and
regeneration after peripheral nerve injury. The DRG
changes after nerve injury are related to up- and down-
regulation of proteins, rapid modulation of satellite glial
cells (SGC) activity, invasion of macrophages [3,4], and
cytokine expression [5,6].
Interleukin 6 (IL-6) serves as a pleiotropic cytokine in
various tissue systems, depending on the target cell and
actual cell conditions [7]. In the nervous system, IL-6 con-
tributes to the survival of axotomized neurons, growth
and differentiation of neurons, formation of dendrites,
neurotransmitter metabolism, and other processes [8,9].
IL-6 is able to promote axonal regeneration [10], but thereLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Results from behavioral tests. Data are for rats 1 d before
operation and the same rats operated upon to create unilateral CCI of
the sciatic nerve for 3 and 14 d. Progressive development of evoked
mechanical allodynia (A) and thermal hyperalgesia (B) was found in
the ipsilateral hind paws. No significant changes of mechanical
allodynia and thermal hyperalgesia were observed in either
contralateral hind paws or forepaws. Data are expressed as relative
change of values in comparison to values measured 1 d before
operation, such that a value of 1 indicates no change. *Indicates
statistically significant difference (p < 0.05) when compared with
measurement 1 d before operation.
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neuropathic pain [5,11]. IL-6 mRNA is scarcely detected
in intact sciatic nerve [12], DRG [13], and the spinal cord
[5], but it is increased following nerve injury [13]. It has
been shown that some cytokines, chemokines and their
receptors are induced bilaterally in lumbar DRG [14,15]
and also in remote cervical DRG after unilateral sciatic
nerve injury [15,16].
IL-6 signals are mediated through a cell-surface cytokine
receptor complex consisting of the ligand-binding IL-6Rα
chain and the signal-transducing component gp130.
gp130 functions as the common receptor for a function-
ally and structurally similar family of cytokines including
IL-6, leukemia inhibitory factor (LIF), ciliary neurotrophic
factor (CNTF), oncostatin M, cardiotrophin-1, and IL-11
[17]. All sensory neurons express gp130 immunoreactivity,
and its levels and intracellular distribution remain un-
changed up to 14 d following sciatic nerve axotomy
[14,18]. Real-time polymerase chain reaction has revealed
a higher expression of gp130 within the superior cervical
ganglia after axotomy for three members of this cytokine
family (IL-6, IL-11, and LIF) that is accompanied by mod-
est increases in oncostatin M, no changes in CNTF, and
decreases in cardiotrophin-1 [19]. Naïve lumbar DRG have
shown immunofluorescence staining for IL-6R in small
and medium-sized neuronal bodies while SGC displayed
no distinct IL-6R immunoreaction. Unilateral CCI of the
sciatic nerve for 3, 7 and 14 d has been shown to induce
an enhanced IL-6R immunofluorescence in SGC sur-
rounding neuronal somata of L4–L5 DRG ipsilateral to
nerve injury [20].
Sciatic nerve ligature is frequently used as a model for
nerve degeneration/regeneration as well as neuropathic
pain. The primary sensory neurons are affected directly
by nerve injury or indirectly by activated SGC and ad-
joining immune cells that release a variety of molecules
changing the microenvironment of the neurons [21,22].
The majority of neuropathic pain models currently in
use share alternations in hind-limb cutaneous sensory
thresholds following partial injury of the peripheral
nerve as a common feature. The CCI model is well de-
scribed and is associated with the development of spon-
taneous pain-like behavior [23].
The aim of our study was to determine mRNA syn-
thesis of IL-6 and its receptors IL-6R and gp130 in
DRG associated and nonassociated with peripheral
nerve injury in order to explain its existence and
spreading after CCI of the sciatic nerve as an experi-
mental model of neuropathic pain. We show that the
inflammatory response to neuropathic stress is propa-
gated quickly on the expression level from the lumbar
to outlying cervical DRG, but without significant
changes of mechanical allodynia and thermal hyper-
algesia in forepaws.Results
Behavioral tests
All rats operated upon to create CCI of the sciatic nerve
and used for in situ hybridization (ISH) displayed de-
creased withdrawal threshold for mechanical allodynia
(Figure 1A) and thermal hyperalgesia (Figure 1B) in hind
paws ipsilateral to nerve ligatures, thus indicating neuro-
pathic pain at 3 d and 14 d after operation. Contralateral
hind paws and forepaws of both sides did not exhibit sta-
tistically significant changes of withdrawal thresholds for
mechanical allodynia and thermal hyperalgesia when com-
pared with 1 d before operation. Sham-operated rats did
not exhibit mechanical allodynia or thermal hyperalgesia
either ipsilaterally or contralaterally to CCI (not shown).
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No or very weak signals for IL-6 mRNA were observed in
sections of DRG removed from the naïve rats. A weak
staining for IL-6 mRNA was detected in SGC and the
blood vessels of both lumbar and cervical DRG (Figure 2A,
B). A bilateral elevation of staining for IL-6 mRNA was in-
duced in lumbar DRG by unilateral CCI of the sciatic
nerve for 3 d (Figure 2C,D). Surprisingly, we observed also
bilateral elevation of staining for IL-6 mRNA in cervical
DRG (Figure 2E). A similar pattern of IL-6 mRNA staining
was also found bilaterally in both lumbar and cervical
DRG 14 d after CCI (Figure 2F–H). In comparison to
naïve DRG, a distinct intensity of IL6 mRNA staining wasFigure 2 Representative ISH staining of IL-6 mRNA signal. Detection o
A, C, F, I, L), lumbar contralateral DRG (L-DRGc, second column, D, G, J, M)
(first row, A, B), and DRG from CCI- (second and third rows, C–H) and sham
SGC. Scale bars = 50 μm.observed, particularly in neuronal somata of all sizes and
in their SGC. Quantitative densitometry analysis of DRG
neurons with SGC for IL-6 mRNA staining is summarized
in Table 1 (third column). There were significant differ-
ences (p < 0.05) in the staining for CCI-operated animals
in both lumbar and cervical DRG when compared with
naïve DRG. Intense staining for IL-6 mRNA in neuronal
bodies did not usually allow to distinguish staining in the
SGC, which was possible particularly in SGC surrounding
the large neuronal bodies.
By contrast, sections of DRG removed from rats 3 d
(Figure 2I–K) or 14 d (Figure 2L-N) after sham-operation
displayed moderate IL-6 mRNA staining in SGC thatf IL-6 mRNA in sections of lumbar ipsilateral DRG (L-DRGi, first column,
, and cervical DRG (C-DRGn, third column, B, E, H, K, N). Naïve DRG
-operated (fourth and fifth rows, I–N) rats. Arrows indicate position of
Table 1 Staining density for IL-6, IL6R, and gp130 mRNA
Mean density (D ± SD)
Animals Ganglia and time IL-6 IL-6R Gp130
Naïve L-DRGn 0.053 ± 0.006 0.170 ± 0.050 0.320 ± 0.121
C-DRGn 0.042 ± 0.006 0.142 ± 0.042 0.440 ± 0.755
Operated 3D L-DRGi 0.386 ± 0.139* 0.434 ± 0.111* 0.540 ± 0.090
3D L-DRGc 0.427 ± 0.064* 0.405 ± 0.119* 0.450 ± 0.047
3D C-DRGn 0.464 ± 0.069* 0.518 ± 0.119* 0.490 ± 0.394
14D L-DRGi 0.536 ± 0.070* 0.273 ± 0.065* 0.470 ± 0.192
14D L-DRGc 0.419 ± 0.132* 0.165 ± 0.030 0.250 ± 0.182
14D C-DRGn 0.332 ± 0.079* 0.201 ± 0.046 0.440 ± 0.154
Sham-operated 3D L-DRGi 0.045 ± 0.006 0.241 ± 0.053 0.370 ± 0.276
3D L-DRGc 0.062 ± 0.006 0.232 ± 0.030 0.270 ± 0.089
3D C-DRGn 0.056 ± 0.006 0.207 ± 0.062 0.320 ± 0.459
14D L-DRGi 0.075 ± 0.010 0.208 ± 0.033 0.290 ± 0.544
14D L-DRGc 0.074 ± 0.007 0.159 ± 0.015 0.340 ± 0.058
14D C-DRGn 0.085 ± 0.005 0.210 ± 0.040 0.490 ± 0.309
*Statistical significance (p < 0.05) when compared with naïve DRG.
Results of staining density for mRNA in lumbar ipsilateral (L-DRGi), lumbar contralateral (L-DRGc), and cervical (C-DRGn) dorsal root ganglia removed from naïve
(Naïve), CCI- and sham-operated rats for 3 and 14 d of survival (3D, 14D).
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sity of IL-6 mRNA staining was observed in SGC of DRG
removed at 14 d (Figure 2L–N) than at 3 d (Figure 2I–K)
from sham operation. However, quantitative analysis of
neurons with SGC for IL6 mRNA staining did not show
significant changes in the staining within DRG from
sham-operated animals when compared to naïve DRG
(Table 1). Control sections incubated without any probe
and with sense oligonucleotide probes displayed no color
staining (Additional file 1A–C).
In parallel with ISH, we analyzed changes of IL-6 pro-
tein in DRG. No or very weak immunofluorescence for
IL-6 protein was observed in sections of DRG removed
from the naïve rats (Additional file 2A). Increased stain-
ing for IL-6 protein was induced in both lumbar and
cervical DRG by unilateral CCI of the sciatic nerve for 3
d (Additional file 2B–D) and for 14 d (not shown). The
results of IL-6 protein elevation by in situ proteomics
are in agreement with the increased corresponding
mRNA signals detected by ISH.IL-6R and gp130 mRNAs in DRG of naïve, CCI- and
sham-operated rats
A weak signal for IL-6R mRNA was observed in neuronal
bodies and SGC in sections of both lumbar and cervical
DRG removed from the naïve rats (Figure 3A, B).
Bilateral elevation of staining for IL-6R mRNA was in-
duced in neuronal bodies of all sizes and SGC of lumbar
(Figure 3C,D) and cervical (Figure 3E) DRG afterunilateral CCI of the sciatic nerve, and especially after 3
d. The elevation of IL-6R mRNA was not so strong at 14
d from CCI (Figure 3F–H). The pattern and intensity of
staining for IL-6R mRNA were very similar in both cer-
vical and lumbar DRG sections for each period of sur-
vival. Quantitative analysis of neurons with SGC for
density of IL-6R mRNA staining is summarized in Table 1
(fourth column). There were significant differences (p <
0.05) in the staining for CCI-operated animals only 3 d
after operation in both lumbar and cervical DRG when
compared with naïve DRG. Even though we observed
some changes 14 d after operation, significant differences
were measured only in ipsilateral lumbar DRG at this
time. However, sections of DRG removed at 3 d
(Figure 3I–K) or 14 d (Figure 3L–N) from sham-operated
rats displayed IL-6R mRNA staining comparable to the
signal in naïve rats (Figure 3A,B). Modest increase of
IL-6R mRNA staining without statistical significance was
detected in neurons and SGC by quantitative analysis for
sections of DRG removed at 3 d or 14 d from sham-
operated rats (Table 1). We analyzed also changes of
IL-6R protein in DRG in relation to IHC. While in DRG
of naïve rats a very weak signal for IL-6R protein was
detected (Additional file 3A), a considerable elevation of
immunofluorescence for IL-6R protein was observed in
both lumbar and cervical DRG from rats operated on CCI
for 3 d (Additional file 3B–D). These results from protein
analyses are in agreement with our ISH results.
In contrast to IL-6 and IL-6R mRNA, we observed in-
tense signal for gp130 mRNA in sections of DRG
Figure 3 Representative ISH staining of IL-6R mRNA signal. Detection of IL-6R mRNA in sections of lumbar ipsilateral DRG (L-DRGi, first
column, A, C, F, I, L), lumbar contralateral DRG (L-DRGc, second column, D, G, J, M), and cervical DRG (C-DRGn, third column, B, E, H, K, N). Naïve
DRG (first row, A, B), and DRG from CCI- (second and third rows, C–H) and sham-operated (fourth and fifth rows, I–N) rats. Arrows indicate
position of SGC. Scale bars = 50 μm.
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bodies and SGC (Figure 4A,B). A similar pattern of
staining was observed also in operated (Figure 4C–H)
and sham-operated (Figure 4I–N) animals in all analyzed
lumbar and cervical DRG. Densitometry of neurons with
SGC for gp130 mRNA staining is summarized in Table 1
(fifth column). Although quantitative evaluation showed
slight changes in the intensity of signals, there were no
significant differences between the signals at any of the
tested times. The control sections incubated with sense
oligonucleotide probes for both IL-6R (Additional file
1D–F) and gp130 (Additional file 3G–I) displayed no
color staining.Double-staining by ISH and GFAP immunostaining
The presence of IL-6 mRNA in SGC was verified by
double-staining for IL-6 mRNA. Glial fibrillary acidic
protein (GFAP) was used as a marker of SGC. The co-
localization of IL-6 mRNA with GFAP immunostaining
was evident particularly at SGC surrounding large
neuronal bodies (Figure 5A–C).
Discussion
Cytokines play a crucial role as intercellular messengers
of immune reaction to nervous system injury [24,25].
Under normal conditions, the production of cytokines
aids the immune system in reaction to pathogens and
Figure 4 Representative ISH staining of gp130 mRNA signal. Detection of gp130 mRNA in sections of lumbar ipsilateral DRG (L-DRGi, first column,
A, C, F, I, L), lumbar contralateral DRG (L-DRGc, second column, D, G, J, M), and cervical DRG (C-DRGn, third column, B, E, H, K, N). Naïve DRG (first row, A,
B), and DRG from CCI- (second and third rows, C–H) and sham-operated (fourth and fifth rows, I–N) rats. Arrows indicate position of SGC.
Scale bars = 50 μm.
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pro-inflammatory cytokine release can induce or facili-
tate neuropathic pain [26]. Neuropathic pain refers to a
variety of chronic pain conditions with differing under-
lying pathophysiological mechanisms and origins. Glial
cells contribute importantly to the creation of enhanced
pain states [27]. Following peripheral nociceptive activa-
tion via nerve injury, microglia become activated, release
pro-inflammatory cytokines, and thereby initiate the
pain process. Microglia propagates neuroinflammation
by recruiting other microglia and eventually activating
nearby astrocytes, which prolongs the inflammatory
state and leads to a chronic neuropathic pain condition.
[28]. Current therapies for pain management include thepervasive utilization of opioids [29]. Activated glial cells
disrupt the pain-suppressive effects of opioid drugs and
contribute to opioid tolerance and opioid dependence/
withdrawal [30].
IL-6 is a pleiotropic cytokine with a diverse range of
actions, including modulation of the peripheral and cen-
tral nervous systems as well as several post-injury ef-
fects. CCI of the sciatic nerve induces neuropathic pain
and synthesis of IL-6 in DRG [13,20]. It also has been
demonstrated that administration of IL-6 neutralizing
antibody significantly decreases allodynia [31]. Targeting
of IL-6 signaling pathways in injured nerve may provide
a novel therapeutic window for treating neuropathic
pain associated with nerve injury [32].
Figure 5 Representative double-staining of IL-6 mRNA by ISH and immunofluorescence for glial fibrillary acidic protein (GFAP).
Detection of IL-6 mRNA in section of ipsilateral L4 DRG from sham-operated rat 14 d after surgery (A) and simultaneous immunofluorescence
staining for GFAP (B). Signal for IL-6 mRNA was co-localized with GFAP immunofluorescence in SGC (C). The nuclei were labeled by Hoechst
33342. Arrows indicate position of SGC. Scale bars = 50 μm.
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sensory neurons of rat DRG after nerve transection or
constriction [13,33]. Available data show that IL-6 tran-
scription is induced specifically in DRG cells, even if
retrograde transport from the periphery cannot be ex-
cluded [34,35]. Our results revealed that IL-6 mRNA
was increased not only in DRG affected by nerve injury
but also in the contralateral DRG. Moreover, we ob-
served bilateral increased staining for IL-6 mRNA also
in cervical DRG nonassociated with nerve subjected to
CCI. The presence of IL-6 protein and gp130 protein in
lumbar DRG had previously been confirmed also by
western blot analyses [14,36]. Our results are in accord-
ance with a growing body of evidence that unilateral
nerve injury evokes bilateral responses [15,16,37], as well
as with bilateral propagation of neuroinflammatory reac-
tion in DRG along the neuraxis from the spinal seg-
ments related to segments nonrelated to injured nerve
[16,38]. In addition to its occurrence in the neurons, im-
munohistochemical staining has revealed IL-6 protein
also in SGC [20]. Our results from double-staining of
ISH for IL-6 mRNA and GFAP immunostaining con-
firmed the synthesis of IL-6 not only in the DRG neurons
but also in their SGC. Interleukin 6 signals through a cell-
surface cytokine receptor complex consisting of the
ligand-binding IL-6Ra chain and the signal-transducing
component gp130. Alternatively, IL-6 may act via a sol-
uble form of the IL-6R generated by limited proteolysis of
the membrane-bound receptor or by alternative splicing
of IL-6R mRNA [39]. Some experimental results have sug-
gested that IL-6R is not synthesized by DRG neurons [40].
Our experiments reported here revealed significant eleva-
tion of IL-6R mRNA staining in neuronal bodies of all
sizes as well as in SGC surrounding mainly large neurons
of DRG removed from CCI-operated rats when compared
with those of naïve rats. This is in agreement with our pre-
viously published results of immunostaining for IL-6R
protein in DRG after CCI of the sciatic nerve [20].Expression of gp130 mRNA and protein has been de-
scribed in neuronal bodies rather than SGC of the rat
DRG [18]. In accordance with our previous results [14],
however, we detected gp130 mRNA expression in both
neuronal bodies and SGC of DRG and its unaltered levels
after CCI. This indicates that the basic level of gp130 is
sufficient for signaling in response to IL-6 elevation after
neuropathic stress. Moreover, gp130 is also an important
receptor for other ligands, such as LIF, CNTF, oncostatin
M, cardiotrophin-1, and IL-11. Similar changes of IL-6
and IL-6R mRNAs found bilaterally in both lumbar and
cervical DRG following unilateral CCI of the sciatic nerve
suggest their common principal regulation.
What signaling is involved in extending DRG reaction
to heteronymous levels has not yet been clearly eluci-
dated. The neuronal signaling of physiological imbalance
induced by unilateral nerve injury could be transferred
to homonymous contralateral or heteronymous DRG of
both sides by neuronal activity along the neuronal path-
ways (e.g., through interneurons at the spinal cord seg-
ment or supraspinal levels) [41]. It is also known that
ascending propriospinal systems link lumbar and cer-
vical spinal cord segments [42]. This mechanism of
propagating mRNA changes in DRG from lumbar to
cervical segments is supported by findings that the
expression of IL-6 mRNA in neurons is regulated by
membrane depolarization [43]. Thus, an increased level
of IL-6 mRNA in heteronymous DRG nonassociated
with damaged nerve might be explained by transmission
of neuronal activity from lumbar to cervical segments.
Moreover, our findings of bilateral changes in TNF-α,
IL-10, and CB-2 protein levels in DRG homonymous and
heteronymous with damaged nerve indicate that transfer
via the bloodstream cannot be excluded [16,44]. The blood
flow is probably another route for dissemination of the
signaling molecules from injured nerve stump to the prox-
imity of DRG neurons not only associated but also
nonassociated with the damaged nerve [15,16,38]. Peri-
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vealed that a number of immune products are early media-
tors of the resultant allodynias, including proinflammatory
cytokines, reactive oxygen species, and complement. Thus,
these immune-derived substances can markedly alter sen-
sory nerve functions [45]. Many clinical pain syndromes
are associated with mirror-image allodynia [46]. Although
our experiments did not confirm allodynia in the contralat-
eral segments, it can be assumed that some cytokines par-
ticipate in initiating these processes.
In our experiments, we applied the sciatic nerve
ligation using a 3–0 sterilized thread (Ethicon) under
aseptic conditions to study neuropathic pain induction
and levels of IL-6, IL-6R, and gp130 mRNAs in DRG.
Therefore, the changes of mRNA levels in the ipsi- and
contralateral L4–L5 as well as C7–C8 DRG were largely
induced by traumatic nerve injury as a manifestation of
accompanying neuroinflammatory response. Notable dif-
ferences in IL-6 and IL-6R mRNAs were found between
DRG from operated and sham-operated animals. With
low staining for IL-6 and IL-6R mRNAs in neuronal
bodies, a mild but distinct expression was observed in
SGC of DRG from sham-operated animals. This activation
of SGC in DRG after sham operation is supported by find-
ings that skin incision led to proliferation of SGC [47] and
increased expression of ATF3 and other regeneration-
associated genes in DRG [48]. We assume that even under
aseptic conditions, sham operation without nerve injury
leads to local production of tissue injury signals that
spread via the bloodstream to DRG where they may acti-
vate SGC. This is supported by evidence that DRG are free
of blood–nerve barrier [49].
While it is broadly accepted that pro-inflammatory cyto-
kines are involved in induction of neuropathic pain
[50,51], the particular role of IL-6 is a subject of contro-
versy. It has been shown that exogenous administration of
IL-6 is sufficient to stimulate nociceptors and cause pain
[11,52,53]. It has been reported, however, that an increase
in plasma IL-6 did not induce a hyperalgesic effect that
would indicate IL-6 effects in the nervous structures, e.g.,
in DRG or the spinal cord [53,54]. In contrast to exogen-
ous administration, endogenous IL-6 of the spinal cord
can inhibit nociceptive transmission in neuropathic rats
and thereby be a potential modulator of neuropathic pain
[55,56]. Our results showing IL-6 and IL-6R up-regulation
in lumbar DRG ipsilateral to nerve injury do not exclude
the possibility that IL-6 signaling plays a role in inducing
the behavioral signs of neuropathic pain. On the other
hand, it should be stressed that additional molecular
mechanisms are needed to induce neuropathic pain.
However, increased IL-6 and IL-6R mRNA levels were
found also in contralateral lumbar and cervical DRG
while not correlating with signs of neuropathic pain.
This significant expression of IL-6 and IL-6R mRNAs inDRG nonassociated with injured nerve suggests other
functional involvement of IL-6 signaling, such as a gen-
eral neuroinflammatory reaction of the nervous system
to injury. For example, IL-6 plays a role in promoting
neuronal survival and axonal growth by DRG neurons
[40,57,58]. In addition, it has been demonstrated that
primary lesion promotes axon regeneration in contralat-
eral nerve [37,59]. Therefore, we suppose that increased
IL-6 and IL-6R mRNA in the primary sensory neurons
of DRG nonassociated with damaged nerve might also
be related to their conditioning through reactivation of
an intrinsic growth program to regenerate their axons.Conclusions
No detectable or very low signals for IL-6 and IL-6R
mRNAs were observed in neuronal bodies and their
SGC of DRG from naïve rats. Unilateral CCI of the sci-
atic nerve induced a bilateral increase of staining for
IL-6 and IL-6R mRNAs in neuronal bodies and SGC of
both lumbar and cervical DRG while mechanical allo-
dynia and thermal hyperalgesia were regularly measured
only in hind paws ipsilateral to the injured nerve. In
contrast, the gp130 mRNA level did not change in the
neuronal bodies and SGC in DRG from naïve versus
CCI-operated rats.
The data provide evidence for increase of IL-6 and
IL-6R mRNA levels not only in DRG directly associated
with damaged nerve but also in those nonassociated
with the injured nerve of the experimental neuropathic
pain model. The results suggest effective propagation of
signal molecules along the neuraxis to remote cervical
DRG as a general neuroinflammatory reaction of the
nervous system to local nerve injury.
Methods
Animals and surgical procedures
Thirty pathogen-free Wistar rats (male, 250–300 g) used
for the experiments were housed on a 12 h light/dark
cycle at temperature 22–24°C under specific pathogen-
free conditions in the animal housing area of Masaryk
University. Sterilized standard rodent food and water
were available ad libitum. All experimental procedures
were carried out aseptically and according to protocols
approved by the Animal Investigation Committee of the
Faculty of Medicine, Brno, Czech Republic and followed
ethical guidance [60].
Surgical procedures were performed under deep
anesthesia using equal volumes of ketamine (40 mg/ml)
and xylazine (4 mg/ml) solutions administered intraperi-
toneally (0.2 ml/100 g body weight). To create CCI, the
right sciatic nerve was exposed at mid-thigh level by
blunt dissection just proximal to its trifurcation, and
three ligatures (3–0 Ethicon) were tied around the nerve
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mately one-third. Animals operated upon to create CCI
were left to survive for 3 or 14 d, representing the early
and later period of survival. DRG removed from intact
rats were used as naïve controls. The right sciatic nerves
of sham-operated rats were only exposed without any
nerve lesion and animals were also allowed to survive
for 3 or 14 d.
Behavioral tests
To ensure rats developed clear signs of neuropathic
pain, mechanical allodynia and thermal hyperalgesia
were measured in hind paws and forepaws before and
after operation.
Mechanical allodynia was measured on a Dynamic
Plantar Aesthesiometer apparatus (Ugo Basile, Comeria,
Italy) according to the manufacturer’s manual. For test-
ing, each rat was placed into a Plexiglas box with metal
grid bottom. After 15 min of acclimatization there was
applied to its paws rigid Von Frey filament with diam-
eter 0.5 mm to a pressure of 50 grams. Threshold re-
sponses of paws were measured 4 times for each paw
with 5 min intervals between tests 1 d before operation
and at the final day of each survival period.
Thermal hyperalgesia was measured on a Plantar Test
Instrument (Ugo Basile) according to the manufacturer’s
manual. Each rat was placed in a Plexiglas box with plas-
tic bottom. After 15 min of acclimatization a heat beam
was applied to its paws. The intensity of radiance was
set at value 50. The value of withdrawal latency was
measured 4 times for each paw with 5 min intervals be-
tween tests 1 d before operation and at the end of each
survival period. Maximum measurement time was 30 s
to prevent tissue damage.
Mean values of behavioral measurement obtained for
all animals 1 d prior to surgery were set as 1. Data for
mechanical allodynia and thermal hyperalgesia after
operation were expressed as relative changes in sensi-
tivity of the same animal from 1 d before operation.
Behavioral data were evaluated using Kruskal–Wallis
one-way analysis of variance and p values less than
0.05 were considered to be significant. There were no
statistically significant differences in sensitivity between
left and right forepaws, so we analyzed results of forepaws
sensitivity as a single set.
In situ hybridization (ISH)
For DRG tissue harvesting, four naïve rats, the next four
rats operated upon to create CCI for each period of sur-
vival (3 and 14 d), and sham-operated rats for 3 (n = 4)
and 14 (n = 4) days were deeply anesthetized with a le-
thal dose of sodium pentobarbital (70 mg/kg body
weight, i.p.) and perfused transcardially with 500 ml
phosphate buffered saline (PBS, 10 mM sodiumphosphate buffer, pH 7.4, containing 0.15 M NaCl and
0.1% diethylpyrocarbonate [DEPC]) followed by 500 ml
of 4% paraformaldehyde containing 0.1% DEPC. The
DRG samples were then washed in 20% phosphate buff-
ered sucrose for 12 h and blocked in Tissue-Tek® OCT
compound (Miles, Elkhart, IN, USA). Serial longitudinal
cryostat sections (12 μm) through the DRG were
mounted on chrome-alum covered slides.
To localize gene transcripts, ISH was performed
according to the protocol of Harnicarova et al. [61]. We
used 50-mer oligoprobes synthesized for the target gene
transcripts. Digoxigenin (DIG)-dT was used for probe
labeling, the sites of which are indicated by asterisks. Se-
quences of oligoprobes were as follow: IL-6 - (1) 5′DIG-
CGC TGT TCA T AC AAT* CAG AAT TGC CAT*
TGC ACA ACT CT*T T TCT CAT TTC C-3′DIG; (2)
5′DIG- TCA AGT GCT TTC AAG AT*G AGT TGG
ATG GTC TTG GT*C CTT AGC CAC TCC TTC -3′
DIG; Il-6R - 5′ DIG-AGT GTG TTT CCC GT*G GTA
GTC CAT TCT CTG CT*C TGT GAG CCT GAG TAC
3′; and gp130 - (1) 5′ DIG-CGC TTT GGA TGG T*CT
GTC TTC AT*A TGT GGT CCC GCT* CGC CTC
CTC ACT 3′; (2) 5′ DIG-TCC CAG CAG CGT* TGT
CAG GAG GAA AGC T*A AGC ACA CAG GCA CGA
CTA T 3′ (VBC-Biotech, Vienna, Austria). All solutions
used in this procedure were prepared in double-distilled
water treated with DEPC. Digoxigenin was detected by
DIG Colorimetric Nucleic Acid Detection Kit (Roche). The
sections were mounted in a Vectashield aqueous mounting
medium (Vector Laboratories, Burlingame, CA, USA) and
analyzed using a Leica DMLB microscope equipped with a
Leica DFC-480 camera (Leica Microsystems, Wetzlar,
Germany). The control sections incubated while omitting
the DIG-oligonucleotide probes and with sense oligoprobes
displayed no color staining.
Double-staining by ISH and GFAP immunostaining
To prove IL-6 mRNA signals in SGC, we used simultan-
eous fluorescence ISH and immunostaining of glial
fibrillary acidic protein (GFAP). Digoxigenin from ISH
was detected by incubation with an anti-DIG monoclonal
antibody that was fluorescein isothiocyanate conjugated.
The sections were then washed with PBS containing
0.05% Tween 20 (PBS-TW20) and 1% bovine serum albu-
min (BSA) for 10 min, treated with 5% normal donkey
serum in PBS-TW20 for 30 min, and incubated with
25 μl of GFAP antibody (Dako, Glostrup, Denmark) in
a humid chamber at room temperature (21–23°C) for
2 h. The GFAP immunoreaction was visualized by
treatment with tetramethyl rhodamine isothiocyanate
(TRITC)-conjugated and affinity-purified donkey anti-
rabbit antibody for 90 min at room temperature. Sections
of naïve DRG and those removed from rats operated upon
to create CCI for both survival periods as well as from
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the identical conditions. Immunostained sections were
rinsed, stained with Hoechst 33342 to detect positions of
the cell nuclei, then mounted in a Vectashield aqueous
mounting medium (Vector Laboratories Inc, Burlingame,
CA, USA). The control sections were incubated while
omitting the primary antibody and displayed no immu-
nostaining. The immunostained sections were observed
and analyzed using a Leica DMLB epifluorescence
microscope equipped with appropriate filter combina-
tions and a Leica DFC-480 camera (Leica Microsystems,
Wetzlar, Germany).
Immunohistochemistry (IHC)
Sections of DRG from naïve and operated rats were im-
munostained simultaneously under the same conditions.
They were washed with PBS containing 0.05% Tween 20
(PBS-T) and 1% BSA for 10 min, treated with 5% normal
donkey serum in PBS-T for 30 min, and incubated with
25 μl of rabbit polyclonal antibodies against IL-6 (1:500;
Invitrogen, Camarillo, CA, USA) or IL-6R (1:200; Santa
Cruz Biotechnology, Santa Cruz, CA, USA) in a humid
chamber at room temperature (21–23°C) for 12 h. The
immunohistochemical reaction was visualized by treat-
ment with TRITC-conjugated and affinity-purified don-
key anti-rabbit secondary antibody (1:100; Millipor,
Billerica, MA, USA) for 90 min at room temperature.
The control sections were incubated without the pri-
mary antibody. Sections were mounted in aqueous
mounting medium (Vectashield; Vector Laboratories
Inc., Burlingame, CA, USA) and analyzed using an epi-
fluorescence microscope (DMLB; Leica Microsystems
GmbH, Wetzlar Germany) equipped with a camera
(DFC-480; Leica Microsystems) and a stabilized power
supply for the lamp housing.
Statistical analyses
Behavioral data and data for staining density of IL-6
mRNA were evaluated using Kruskal–Wallis one-way
analysis of variance and p values less than 0.05 were
considered to be significant. All statistical analyses were
performed using STATISTICA 9.0 software (StatSoft,
Tulsa, OK, USA).
Additional files
Additional file 1: Control sections incubated with sense
oligonucleotide probes displayed no color staining. Detection by
sense IL-6 probe (first lane, A-C), sense IL-6R probe (second lane, D-F),
and sense GP130 probe (third lane, G operated (second and third rows, B,
C, E, F, H, I) rats. Scale bars = 50 μm. H). Naïve DRG (first column, A, D, G)
and DRG from CCI.
Additional file 2: Sections illustrating immunofluorescence staining
for IL-6 protein in lumbar DRG from naive rat (A) and lumbar DRG
from ipsilateral (B, L-DRGi) and contralateral side (C, L-DRGc) as wellas cervical DRG (D, C-DRGn) of rat 3 d from CCI of the sciatic nerve.
Increased immunofluorescence was observed mainly in neuronal bodies
of both lumbar and cervical DRG. Scale bars = 50 μm.
Additional file 3: Sections illustrating immunofluorescence staining
for IL-6R protein in lumbar DRG from naive rat (A) and lumbar DRG
from ipsilateral (B, L-DRGi) and contralateral side (C, L-DRGc) as well
as cervical DRG (D, C-DRGn) of rat 3 d from CCI of the sciatic nerve.
Increased immunofluorescence was observed mainly in neuronal bodies
of both lumbar and cervical DRG. Scale bars = 50 μm.
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